Prediabetes is not an approved use for Zepbound, but the progression-to-diabetes question keeps it in view. This overview walks through the dual-incretin mechanism, what the STEP and SURMOUNT populations tell us, the safety profile, and the genetic pathways shaping metabolism.

Prediabetes is not an FDA-approved indication for Ozempic, yet the drug keeps surfacing in these searches. This page explains what semaglutide is, the insulin-sensitivity hypothesis behind the interest, where the published trial record actually stops, and the inherited variants that shape your metabolic starting line before any medication.